Bernt van den Blink Selected Research

PRM-151

1/2019	Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study.
3/2016	Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernt van den Blink Research Topics

Disease

8	Idiopathic Pulmonary Fibrosis 10/2019 - 12/2010
3	Disease Progression 10/2019 - 12/2010
3	Pulmonary Sarcoidosis 01/2018 - 09/2015
3	Sarcoidosis (Schaumann Disease) 01/2018 - 01/2012
3	Endotoxemia 01/2004 - 04/2002
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2019 - 12/2010
2	Fibrosis (Cirrhosis) 03/2016 - 01/2015
2	Granuloma 12/2013 - 01/2012
2	Crohn Disease (Crohn's Disease) 08/2005 - 01/2002
1	Systemic Scleroderma (Systemic Sclerosis) 01/2015
1	Pneumonia (Pneumonitis) 05/2013
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2012
1	Tuberculosis (Tuberculoses) 01/2012
1	Lung Injury 12/2010
1	Inflammation (Inflammations) 04/2002
1	Ulcer 01/2002

Drug/Important Bio-Agent (IBA)

3	p38 Mitogen-Activated Protein KinasesIBA 01/2004 - 04/2002
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 12/2010
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2019 - 12/2010
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2010
2	PRM-151IBA 01/2019 - 03/2016
2	CytokinesIBA 12/2013 - 05/2013
2	semapimodIBA 08/2005 - 01/2002
1	Immunoglobulin A (IgA)IBA 10/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	SteroidsIBA 01/2018
1	InterferonsIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 03/2016
1	Fas Ligand Protein (Fas Ligand)IBA 09/2015
1	CTLA-4 AntigenIBA 09/2015
1	pirfenidoneIBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	ChemokinesIBA 12/2013
1	Interleukin-22 (IL-22)IBA 05/2013
1	InterleukinsIBA 05/2013
1	Interleukin-17 (Interleukin 17)IBA 01/2012
1	Surface-Active Agents (Surfactants)IBA 12/2010
1	Peptide Hydrolases (Proteases)FDA Link 12/2010
1	Proteinase-Activated ReceptorsIBA 12/2010
1	CollagenIBA 12/2010
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2010
1	Thromboplastin (Tissue Factor)IBA 12/2010
1	CXCR ReceptorsIBA 01/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2002
1	Phosphotransferases (Kinase)IBA 01/2002
1	Mitogen-Activated Protein KinasesIBA 01/2002

Therapy/Procedure

5	Therapeutics 12/2018 - 12/2010
2	Lung Transplantation 12/2015 - 01/2012
1	Drug Tapering 01/2018